PharmTech AI Pulse Check: Fixing AI Slop at the Source

AI-generated "slop" has become a fixture of daily inboxes, but is it creeping into pharmaceutical manufacturing and quality documentation? That's the question at the center of Part 1 of the debut episode of the new PharmTech AI Pulse Check series, in which host Christopher Cole is joined by Richard Jaenisch, Senior Director of Education, Outreach, and Digital Experience at OpenBiopharma Research and Training Institute; Florin Muraru, an independent regulatory affairs executive with more than 20 years of experience; and Gourav Pandey, quality and CMC risk and compliance specialist at Takeda, unpack where AI-generated content is showing up in SOPs, deviation reports, and literature summaries, as well as who's responsible for catching it before it reaches a regulator.